The aim of this trial was to test the effects of the use of eubiotics (pro- and prebiotics) alone or in combination in the diet of lambs finished under subtropical climate conditions. For this purpose, 40 Pelibuey × Katahdin lambs (29.5 ± 4.8 kg initial live weight) were used in a 93 day growth-performance experiment. Dietary treatments consisted of a cracked corn-based finishing diet supplemented with (1) no eubiotics (control), (2) 3 g of probiotics (live Saccharomyces cerevisiae, SC), (3) 3 g of prebiotics (mannan oligosaccharide plus b-glucans, MOS), and (4) a combination of 1.5 g of SC and 1.5 g of MOS (SC+MOS). Throughout the study, the average temperature humidity index (THI) was 78.60. Compared to controls, supplementation with SC or MOS, alone did not affect average daily gain (ADG), but enhanced feed efficiency by 5.6% and 6.9% (gain-to-feed ratio, G:F) and dietary net energy by 4.6% and 5.9%, respectively. Compared to controls, SC+MOS enhanced ADG (10%), G:F (9.5%), and dietary net energy (7.2%). Lambs fed SC+MOS had also greater ADG, G:F, and dietary net energy compared to lambs fed SC alone. When compared to MOS, the combination enhanced ADG (10.4%, p = 0.04). This effect could be attributed to the increased dry matter intake (7.6%, p = 0.06), as neither G:F nor dietary energy was significantly affected. Compared with controls and SC, supplementation with MOS alone and SC+MOS increased kidney–pelvic–heart fat, while SC supplementation tended (p = 0.08) to reduce 4.1% the relative intestinal mass (as a proportion of empty body weight) when compared to controls. Treatment effects on the other carcass measures were not significant. In the present study, supplemental probiotics and/or prebiotics improved dietary energetic efficiency in lambs finished under subtropical climatic conditions. The combination of probiotics with prebiotics reinforced this positive effect.

Two experiments were conducted to compare a supplemental blend of essential oils alone (EO) or combined with enzymes (EO + ENZ) versus virginiamycin (VM), on characteristics of growth performance (Exp. 1) and digestion (Exp. 2) in finishing lambs. Lambs were fed a high-energy finishing diet supplemented with: (1) no supplement (control); (2) 150 mg supplemental EO; (3) 150 mg supplemental EO plus 560 mg alpha-amylase (EO + ENZ); and 4) 25 mg VM. Compared with the control, growth performance response to EO and VM were similar, enhancing (5.7%, p < 0.05) feed efficiency and observed dietary net energy. Compared with control, supplementation with EO + ENZ tended (p = 0.09) to increase dry matter intake (6.8%), improving (p < 0.05) weight gain and feed efficiency (10.4 and 4.4%, respectively). Dietary energy utilization was greater (2.7%, p < 0.05) for EO and VM than EO + ENZ. Treatment effects on the carcass and visceral mass were small, but additive supplementation decreased (p ≤ 0.03) the relative weight of the intestines. There were no treatment effects on measures of digestion nor digestible energy of the diet. Supplemental EO may be an effective alternative to VM in high-energy finishing diets for feedlot lambs. Combination EO + ENZ may further enhance dry matter intake, promoting increased weight gain.

Background: The genus Randia L. (Rubiaceae) is native to Americas and highly distributed in tropical areas. Some Randia species are used in traditional medicine in some countries to treat diverse illnesses/symptoms of kidney, circulatory system, lungs, diabetes, cancer, inflammation, and against the bites/stings of snakes and other poisonous animals. Questions: What are the phytochemical compounds previously identified in Randia ? What biological activities do they present? Data description: Twenty-eight studies on chemical composition and biological activities of Randia were reviewed. Species names were corroborated in Plants of the World Online and World Flora Online. The site and studied years: Studies of Randia of Americas from 1991 to 2021. Methods: Database reviewed were PubMed, Scopus, Scielo, BVS, DAOJ, Science Direct, Springer Link, Web of Science, and Google Scholar, employing the keywords Randia and its synonym Basanacantha . Results: Six species are the most studied ( R. aculeata, R. echinocarpa , R. ferox , R. hebecarpa , R. matudae, and R. monantha ). Ethnopharmacology information of 12 species was recovered. One hundred compounds in Randia have been identified (phenolic acids, terpenes, sterols, and others), and diverse biological activities reported in 24 studies ( e.g. , antimutagenic, antioxidant, and antivenom) have demonstrated for nine species. Conclusions: Biological activities found in some species of Randia support their traditional uses, but only the antivenom effect of Randia aculeata has been demonstrated. Randia species could be a source of bioactive compounds; however, knowledge must be expanded to demonstrate their traditional uses and contribute to the development of strategies for their preservation and rational use.

In Mexico, the mango crop is affected by anthracnose caused by Colletotrichum species. In the search for environmentally friendly fungicides, chitosan has shown antifungal activity. Therefore, fungal isolates were obtained from plant tissue with anthracnose symptoms from the state of Guerrero in Mexico and identified with the ITS and β-Tub₂ genetic markers. Isolates of the Colletotrichum gloeosporioides complex were again identified with the markers ITS, Act, β-Tub₂, GADPH, CHS-1, CaM, and ApMat. Commercial chitosan (Aldrich, lot # STBF3282V) was characterized, and its antifungal activity was evaluated on the radial growth of the fungal isolates. The isolated anthracnose-causing species were C. chrysophilum, C. fructicola, C. siamense, and C. musae. Other fungi found were Alternaria sp., Alternaria tenuissima, Fusarium sp., Pestalotiopsis sp., Curvularia lunata, Diaporthe pseudomangiferae, and Epicoccum nigrum. Chitosan showed 78% deacetylation degree and a molecular weight of 32 kDa. Most of the Colletotrichum species and the other identified fungi were susceptible to 1 g L⁻¹ chitosan. However, two C. fructicola isolates were less susceptible to chitosan. Although chitosan has antifungal activity, the interactions between species of the Colletotrichum gloeosporioides complex and their effect on chitosan susceptibility should be studied based on genomic changes with molecular evidence.